A major new synthesis of research has confirmed that people living with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) face a markedly increased risk of developing cancer. Published in Zeitschrift für Rheumatologie and reported by Hematology Advisor, this systematic review and meta-analysis highlights the need for heightened cancer vigilance and tailored surveillance in this patient population.
Overall Cancer Risk Substantially Higher
Analyzing data from 14 studies that included 5,553 patients with AAV, researchers found that the overall cancer risk was 76.7% higher for AAV patients compared to the general population (standardized incidence ratio [SIR] 1.77). This elevated risk was statistically significant and persisted across nearly all regions studied—Europe, Asia, and Oceania—with the highest risk reported in Asia (SIR 2.19).
Cancer Risk Patterns by Sex, Age, and Disease Subtype
The increased cancer risk was most pronounced in men with AAV, who had more than double the risk of developing cancer compared to the general male population (SIR 2.08). In contrast, the increase in women, while present, did not reach statistical significance. Both younger (≤60 years) and older (>60 years) AAV patients experienced elevated cancer rates, with the younger group showing a slightly higher relative increase.
When broken down by disease subtype, granulomatosis with polyangiitis (GPA) carried a notably high cancer risk (SIR 2.23), while microscopic polyangiitis showed only a non-significant trend toward increased risk.
Specific Cancers with Highest Risk
The analysis pinpointed several cancer types where risk for AAV patients was particularly high:
- Bladder cancer: More than four times the risk compared to the general population (SIR 4.29)
- Leukemia: Over fourfold increased risk (SIR 4.08)
- Nonmelanoma skin cancer: More than tripled risk (SIR 3.60)
- Kidney cancer: Over three times the risk (SIR 3.20)
Elevated—but less dramatic—risks were also observed for lung, brain, liver, oral cavity cancers, and malignant melanoma. Interestingly, the risks for prostate, breast, and stomach cancers, as well as certain lymphomas, did not reach statistical significance, though trends were still upward.
Geography and Study Size Influence Results
The study’s meta-analyses revealed some variability in cancer risk estimates across the included research, with geographic region and sample size identified as key sources of this heterogeneity. However, the overall conclusions remained robust regardless of which individual study was removed from the analysis.
Implications for Patients and Clinicians
This comprehensive review establishes that AAV patients, particularly men and those diagnosed with granulomatosis with polyangiitis, should be considered at high risk for a range of malignancies—especially bladder, blood, kidney, and skin cancers. The findings support the integration of regular and targeted cancer screening into the long-term management of AAV.
As research continues, understanding the mechanisms behind this elevated risk and tailoring prevention strategies will be crucial to improving outcomes for this vulnerable group.
